Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?

Human and mouse CD4+FoxP3+ T cells (Tregs) comprise non-redundant regulatory compartments which maintain self-tolerance and have been found to be of potential therapeutic usefulness in autoimmune disorders and transplants including allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ther...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Sabrina N. Copsel, Dietlinde Wolf, Brent Pfeiffer, Henry Barreras, Victor L. Perez, Robert B. Levy
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2022-06-01
主題:	Tregs GvHD HSCT = hematopoietic stem cell transplant recipient tregs treatment
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.932527/full